Approximately 90% of women of childbearing age use some form of contraception. Despite this, nearly 50% of pregnancies in the United States are unintentional. Of these, 43% result in live births, 13% in miscarriages, and 44% end in elective abortion
No contraceptive or sterilization method is 100% effective
Contraceptive methods and their theoretical and actual failure rates
No method (85.0%/85.0%)
Periodic abstinence (9.0%/25.0%)
Withdrawal (4.0%/27.0%)
Lactational amenorrhea (2.0%/15.0-55.0%)
Male condom (2.0%/15.0%)
Female condom (5.0%/21.0%)
Diaphragm with spermicide (6.0%/16.0%)
Cervical cap with spermicide (Parous women 26.0%/32.0%, Nulliparous women 9.0%/16.0%)
Spermicide alone (18.0%/29.0%)
Copper-T IUD (0.6%/0.8%)
Levonorgestrel IUS (0.1%/0.1%)
Combination pill (0.1%/3.0%)
Transdermal patch (0.3%/0.8%)
Vaginal ring (0.3%/0.8%)
Progestin-only pill (0.5%/8.0%)
Depo-Provera (0.3%/0.3%)
Subdermal implant (0.4%/0.4%)
Female sterilization (0.5%/0.5%)
Male sterilization (0.1%/0.15%)
Theoretical efficacy rate refers to the efficacy of contraception when used exactly as instructed. Actual efficacy rate refers to efficacy when used in real life, assuming variations in the consistency of usage
Natural methods of contraception
Periodic abstinence
Coitus interruptus
Lactational amenorrhea
Periodic abstinence
Physiologic form of contraception that emphasizes fertility awareness and abstinence shortly before and after the estimated ovulation period
Periodic abstinence
Requires instruction on the physiology of menstruation and conception and on methods of determining ovulation
Requires the woman to have regular, predictable menstrual cycles
Ovulation assessment methods may include ovulation prediction kits, basal body temperature measurements, menstrual cycle tracking, cervical mucus evaluation, and/or documentation of any premenstrual or ovulatory symptoms
The average effectiveness of periodic abstinence is relatively low (55% to 80%) compared to other forms of pregnancy prevention
Coitus interruptus
Withdrawal of the penis from the vagina before ejaculation
The failure rate for coitus interruptus is quite high (27%) compared to other forms of contraception
Lactational amenorrhea
Continuation of nursing has long been a widespread method of contraception. After delivery, the restoration of ovulation is delayed because of a nursing-induced hypothalamic suppression of ovulation
50% of lactating mothers will begin to ovulate between 6 and 12 months after delivery, even while breastfeeding. Return of ovulation occurs before the return of menstruation
15% to 55% of mothers using lactation for contraception subsequently become pregnant
Enhancing the effectiveness of lactational amenorrhea
Breastfeeding should be the only form of nutrition for the infant
This method of contraception should be used only as long as the woman is experiencing amenorrhea and only for a maximum of 6 months after delivery
Barrier methods and spermicides
Male condoms
Female condoms
Diaphragm
Cervical caps
Vaginal contraceptive foam
Vaginal contraceptive suppositories
Vaginal contraceptive film
Spermicidal gel
Male condoms
Latex sheaths placed over the erect penis before ejaculation to prevent the ejaculate from being released into the reproductive tract of the woman
When properly used, the condom can be 98% effective in preventing conception. The actual efficacy rate in the population is 85% to 90%
Female condoms
A pouch made of polyurethane that has a flexible ring at each end, with one ring fitting into the depth of the vagina and the other staying outside the vagina near the introitus
The failure rate of the female condom is 20% to 25%, somewhat higher than that of the male condom
Diaphragm
A dome-shaped latex rubber sheet stretched over a thin coiled rim, with spermicidal jelly placed on the rim and on either side, and placed into the vagina to cover the cervix
The theoretical effectiveness of the diaphragm approaches 94%. The actual effectiveness rate of the diaphragm with spermicide is 80% to 85%
Cervical cap
A small, soft, silicone cap that fits directly over the cervix and is held in place by suction, acting as a barrier to sperm
The actual efficacy rate of the cervical cap is 68% to 84% (16% to 32% failure rate), depending on the woman's parity
Spermicides
Agents that disrupt the cell membranes of spermatozoa and act as a mechanical barrier to the cervical canal, including nonoxynol-9 and octoxynol-9
When properly and consistently used with condoms, spermicides can have an effectiveness rate as high as 95%. However, in actual usage, the efficacy of spermicides when used alone is only 70% to 75%
Spermicides do not confer any protection against sexually transmitted infections (STIs) and may make the user more susceptible to STIs including HIV by causing vaginal irritation
Intrauterine devices (IUDs) available in the United States
Copper-T IUD (ParaGard)
Levonorgestrel intrauterine system (Mirena)
Spermicides should not be used by women with HIV or at high risk of contracting HIV, especially in developing nations where contraception and STI prevention are paramount
For the general public, it is strongly recommended that consistent condom use be employed whenever protection against STIs is desired
Intrauterine devices (IUDs)
Devices introduced into the endometrial cavity to prevent pregnancy, used since the 1800s
In the 1960s and 1970s, IUDs became extremely popular in the United States, but legal ramifications stemming from pelvic infections associated with the Dalkon shield resulted in consumer fear and limited availability of all IUDs
Currently, only two IUDs are available in the United States: the intrauterine Copper-T IUD (TCu-380A or ParaGard) and the levonorgestrel intrauterine system (LNG-20 or Mirena)
Despite previous fears, there are nearly 100 million IUD users globally, making the IUD the most widely used method of reversible contraception in the world
IUD is especially indicated for
Women in whom oral contraceptives are contraindicated, those who are at low risk for STIs, and in monogamous women of any age
Levonorgestrel-containing IUD (Mirena)
Can also be used to treat menorrhagia, dysmenorrhea, and used in postmenopausal women receiving estrogen therapy
Absolute and relative contraindications for IUD use
Known or suspected pregnancy
Undiagnosed abnormal vaginal bleeding
Acute cervical, uterine, or salpingeal infection
Copper allergy or Wilson disease (for ParaGard only)
Current breast cancer (for Mirena only)
Prior ectopic pregnancy
History of STIs in past 3 months
Uterine anomaly or fibroid distorting the cavity
Current menorrhagia or dysmenorrhea (for ParaGard only)
Intrauterine devices are introduced into the endometrial cavity
1. Using a cervical cannula
2. IUDs have two monofilament strings that extend through the cervix where they can be checked to detect expulsion or migration
3. The strings also facilitate removal of the device by the clinician
Mechanism of action for IUDs
They act mainly by killing sperm (spermicidal) and preventing fertilization
They elicit a sterile inflammatory response resulting in sperm being engulfed, immobilized, and destroyed by inflammatory cells
They reduce tubal motility that inhibits sperm and blastocyst transport
They do not affect ovulation, nor do they act as abortifacients
The addition of levonorgestrel in the Mirena IUD and copper in the ParaGard IUD further augments their mechanisms of action
Mirena IUD
Progesterone thickens the cervical mucus and atrophies the endometrium to prevent implantation
ParaGard IUD
Copper is thought to hamper sperm motility and capitation so sperm rarely reach the fallopian tube and are unable to fertilize the ovum